|
|
 |
|
Viewing report
|
|
|
|
Treatment Algorithm 2001: Diabetes
Datamonitor, Sep 2001
Around 140 million people suffer from diabetes globally, with 42 million sufferers in the seven major pharmaceutical markets analyzed in this report. The high prevalence of diabetes in the developed world is largely due to the aging population and rapidly expanding obese population, both major drivers of type II diabetes. At present diabetes is a ‘Western’ disease and as such attracts a lot of pharmaceutical company interest, however it is increasingly affecting developing countries, and the global prevalence is set to double over the next 25 years. Diabetes is a serious condition, which if poorly treated can increase the risk of cardiovascular diseases, kidney failure and nerve damage leading to amputation. However, while diabetes remains incurable, the disease is eminently treatable and ranges of products have been developed to control the condition. This report analyzes the treatment of type I and type II diabetes from patient presentation to final therapy, manalyzing the key features of the most successful products.
Customers who bought this item also bought
Br Malls Participacoes Sa
Br. Holdings Corporation
Drugs of Tomorrow 2001: Diabetes
Treatment Algorithms 2001 Breast Cancer: Herceptin Falling into Stride
Treatment Algorithms 2002: Alzheimer's Disease - Aricept: the physicians choice
Strategic Perspectives 2001: Diabetes - Importance of Compliance in Drug Development
Strategic Perspectives 2001: Obesity - An Old Market Attracting New Attention
Treatment Algorithms 2001: Allergic Rhinitis - Unlocking the Real Patient Potential
Treatment Algorithms 2002: Venous Thromboembolism Acute Therapy
Treatment Algorithms 2000: Rheumatoid Arthritis - Defining Changing Treatment Trends
Treatment Algorithms 2002: Heart failure - managing chronic and acute patients
Diabetes
|
|
|
|
